 Maciej Walczak
Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycosides | 7 | 2018 | 33 | 2.330 |
Why?
| | Glycosylation | 8 | 2020 | 131 | 2.010 |
Why?
| | Tin Compounds | 4 | 2018 | 16 | 1.480 |
Why?
| | Peptides | 3 | 2023 | 849 | 1.280 |
Why?
| | Monosaccharides | 2 | 2018 | 11 | 1.210 |
Why?
| | Bridged Bicyclo Compounds | 3 | 2015 | 11 | 1.140 |
Why?
| | Glycoconjugates | 2 | 2018 | 7 | 1.060 |
Why?
| | Stereoisomerism | 6 | 2021 | 91 | 0.990 |
Why?
| | Catalysis | 7 | 2020 | 292 | 0.960 |
Why?
| | Oligosaccharides | 3 | 2018 | 46 | 0.900 |
Why?
| | Coordination Complexes | 2 | 2020 | 11 | 0.900 |
Why?
| | Tauopathies | 1 | 2023 | 7 | 0.890 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2023 | 8 | 0.890 |
Why?
| | Frontotemporal Dementia | 1 | 2023 | 20 | 0.870 |
Why?
| | Glutamate Carboxypeptidase II | 2 | 2013 | 4 | 0.860 |
Why?
| | Copper | 2 | 2020 | 99 | 0.850 |
Why?
| | Butanes | 2 | 2015 | 3 | 0.830 |
Why?
| | Antigens, Surface | 2 | 2013 | 151 | 0.820 |
Why?
| | Polysaccharides | 2 | 2013 | 78 | 0.820 |
Why?
| | Phosphines | 3 | 2018 | 15 | 0.790 |
Why?
| | Borates | 1 | 2021 | 3 | 0.770 |
Why?
| | Disaccharides | 1 | 2021 | 16 | 0.770 |
Why?
| | Morpholines | 2 | 2018 | 102 | 0.730 |
Why?
| | Transition Elements | 1 | 2020 | 3 | 0.730 |
Why?
| | Thioglycosides | 1 | 2020 | 2 | 0.720 |
Why?
| | Proteins | 2 | 2023 | 915 | 0.720 |
Why?
| | Organotin Compounds | 1 | 2020 | 3 | 0.720 |
Why?
| | Sulfur | 1 | 2020 | 46 | 0.710 |
Why?
| | Carbon | 1 | 2021 | 158 | 0.700 |
Why?
| | Free Radicals | 1 | 2020 | 99 | 0.690 |
Why?
| | Molecular Structure | 6 | 2021 | 438 | 0.680 |
Why?
| | Amino Alcohols | 1 | 2018 | 1 | 0.630 |
Why?
| | Amino Acids | 1 | 2022 | 451 | 0.630 |
Why?
| | Carboxylic Acids | 1 | 2018 | 26 | 0.630 |
Why?
| | Alcohols | 1 | 2018 | 28 | 0.630 |
Why?
| | Glyoxal | 1 | 2018 | 11 | 0.620 |
Why?
| | Alzheimer Disease | 1 | 2023 | 436 | 0.620 |
Why?
| | Organoselenium Compounds | 1 | 2018 | 11 | 0.620 |
Why?
| | Galactans | 1 | 2017 | 4 | 0.590 |
Why?
| | Chemistry Techniques, Synthetic | 4 | 2018 | 12 | 0.570 |
Why?
| | Anhydrides | 1 | 2016 | 18 | 0.560 |
Why?
| | Heterocyclic Compounds | 1 | 2015 | 18 | 0.490 |
Why?
| | Palladium | 3 | 2018 | 12 | 0.450 |
Why?
| | Solid-Phase Synthesis Techniques | 2 | 2023 | 12 | 0.430 |
Why?
| | Oligopeptides | 1 | 2013 | 234 | 0.380 |
Why?
| | Cyclization | 4 | 2018 | 15 | 0.380 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2009 | 86 | 0.320 |
Why?
| | Rhodium | 1 | 2008 | 1 | 0.310 |
Why?
| | Cyclobutanes | 1 | 2008 | 5 | 0.310 |
Why?
| | Pyrrolidines | 1 | 2008 | 55 | 0.300 |
Why?
| | Azepines | 1 | 2008 | 74 | 0.300 |
Why?
| | Molecular Conformation | 2 | 2020 | 137 | 0.290 |
Why?
| | Indicators and Reagents | 2 | 2022 | 99 | 0.260 |
Why?
| | Spiro Compounds | 1 | 2004 | 9 | 0.240 |
Why?
| | Aza Compounds | 1 | 2004 | 11 | 0.240 |
Why?
| | tau Proteins | 1 | 2023 | 65 | 0.220 |
Why?
| | Glycine | 1 | 2023 | 153 | 0.210 |
Why?
| | Protein Isoforms | 1 | 2023 | 339 | 0.200 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 177 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 1 | 2023 | 399 | 0.190 |
Why?
| | Esters | 1 | 2021 | 61 | 0.180 |
Why?
| | Peptides, Cyclic | 1 | 2022 | 254 | 0.180 |
Why?
| | Computer Simulation | 2 | 2018 | 881 | 0.180 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 529 | 0.170 |
Why?
| | Models, Chemical | 1 | 2020 | 250 | 0.160 |
Why?
| | Isotopes | 1 | 2018 | 27 | 0.160 |
Why?
| | Ligands | 1 | 2020 | 565 | 0.160 |
Why?
| | Genotype | 1 | 2023 | 1780 | 0.150 |
Why?
| | Carbohydrate Conformation | 1 | 2018 | 15 | 0.150 |
Why?
| | Salts | 1 | 2018 | 35 | 0.150 |
Why?
| | Deuterium | 1 | 2018 | 79 | 0.150 |
Why?
| | Lectins | 1 | 2018 | 44 | 0.150 |
Why?
| | Carbohydrates | 1 | 2018 | 56 | 0.150 |
Why?
| | Mesylates | 1 | 2017 | 8 | 0.150 |
Why?
| | Light | 1 | 2020 | 335 | 0.150 |
Why?
| | Models, Molecular | 2 | 2015 | 1379 | 0.140 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2018 | 165 | 0.140 |
Why?
| | Organometallic Compounds | 1 | 2018 | 98 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2023 | 1019 | 0.140 |
Why?
| | Cell Wall | 1 | 2017 | 52 | 0.140 |
Why?
| | Quantum Theory | 1 | 2017 | 78 | 0.140 |
Why?
| | Acetals | 1 | 2016 | 4 | 0.140 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 503 | 0.140 |
Why?
| | Oxides | 1 | 2016 | 43 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2023 | 1901 | 0.130 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 926 | 0.120 |
Why?
| | Kinetics | 1 | 2018 | 1558 | 0.120 |
Why?
| | Biological Products | 1 | 2017 | 171 | 0.120 |
Why?
| | Tissue Extracts | 1 | 2014 | 20 | 0.120 |
Why?
| | Serine Proteases | 1 | 2014 | 14 | 0.120 |
Why?
| | Phosphorous Acids | 1 | 2014 | 12 | 0.120 |
Why?
| | Molecular Probes | 1 | 2014 | 30 | 0.120 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 268 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2018 | 637 | 0.110 |
Why?
| | Crystallography, X-Ray | 1 | 2015 | 405 | 0.110 |
Why?
| | Mannose | 1 | 2012 | 21 | 0.110 |
Why?
| | Spleen | 1 | 2014 | 486 | 0.100 |
Why?
| | Cancer Vaccines | 1 | 2012 | 137 | 0.100 |
Why?
| | Neutrophils | 1 | 2014 | 1164 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 1990 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2014 | 788 | 0.080 |
Why?
| | Isomerism | 1 | 2008 | 43 | 0.080 |
Why?
| | Humans | 4 | 2023 | 115052 | 0.070 |
Why?
| | Chemistry, Organic | 1 | 2004 | 6 | 0.060 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 102 | 0.030 |
Why?
| | Molecular Weight | 1 | 2014 | 331 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 398 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2014 | 496 | 0.020 |
Why?
|
|
Walczak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|